Pharmaceutical industry
The global market for novel drug delivery systems (NDDS) is expected to experience significant growth, driven by the benefits of controlled-release drug delivery systems, including reduced treatment cost, lower side effects, and enhanced therapeutic efficacy. The adoption of controlled-release drugs is being propelled by the rapidly growing pediatric and geriatric
Pharmaceutical industry
A new report, "Behind the Curtain: The Corporate Plot to Upend Democracy," reveals how 20 corporations or groups, representing them, have spent over $201 million in lobbying to derail important investments and reforms outlined in President Biden's Build Back Better agenda. The report highlights corporations such
Pharmaceutical industry
The global nutricosmetics market has exhibited moderate growth between 2015 and 2020, and it is expected to grow at a compound annual growth rate (CAGR) of around 8% during the forecast period of 2021-2026. The market is driven by factors such as the growing emphasis on maintaining physical appearance, rising
Pharmaceutical industry
Atrial fibrillation, a common and potentially life-threatening cardiac arrhythmia, has been identified as a significant risk factor for patients with diabetes mellitus. A recent study published in Heart Rhythm O2 has sheds light on the clinical outcomes after catheter ablation in patients with and without diabetes mellitus. The research, conducted
Pharmaceutical industry
The multiple myeloma pipeline landscape is rapidly evolving, with numerous companies and research institutions working towards the development of innovative treatment therapies. A report by DelveInsight highlights the presence of over 80 companies and 120 pipeline drugs, indicating a significant surge in research and development efforts. Key players such as
Pharmaceutical industry
The global API market is poised to experience significant growth, driven by factors such as increasing focus on generic and branded drugs, rising investment in drug discovery, and strong adherence to product quality. Amid the COVID-19 pandemic, the market is expected to reach $265.3 billion by 2026, growing at
Pharmaceutical industry
The US military is imposing vaccination deadlines for its service members as the Pentagon enforces its new policy requiring all active-duty, reserve, and National Guard personnel to get vaccinated against Covid-19. The US Army, Air Force, Navy, and Marine Corps have set various deadlines for completion of the vaccination process,
Pharmaceutical industry
American Airlines has announced that it will end company-provided pandemic leave for unvaccinated employees who contract COVID-19, citing the full approval of the Pfizer-BioNTech vaccine by the FDA as a reason to require vaccination. The airline has sent a memo to employees stating that only fully vaccinated employees will be
Pharmaceutical industry
The global Chronic Kidney Disease (CKD) drugs market is projected to grow significantly, driven by the increasing prevalence of CKD and the launch of new drugs. Amid the COVID-19 crisis, the market is estimated to reach $15.5 billion by 2026, growing at a CAGR of 1.9% over the
Pharmaceutical industry
As the world grapples with the ongoing pandemic, a new report by Global Industry Analysts Inc. provides a comprehensive analysis of the COVID-19 vaccines market, highlighting trends, opportunities, and challenges. The report, "COVID-19 Vaccines - Global Market Trajectory & Analytics," offers a fresh perspective on the post-COVID-19 marketplace,
Pharmaceutical industry
Businesses, encouraged by the U.S. Food and Drug Administration's recent full approval of Pfizer's COVID-19 vaccine, are increasingly requiring workers to get vaccinated or face consequences, such as being fired or charged extra for health insurance. Employers feel that a significant push is needed to
Pharmaceutical industry
Markets extended gains on Tuesday as investors reacted positively to the Food and Drug Administration's full approval for the COVID-19 vaccine from Pfizer and BioNTech. Jim Cramer and TheStreet Senior Portfolio Analyst Jeff Marks discussed several stocks on their radar, including Palo Alto Networks, economic-growth stocks, and Boeing.
